Skip to main content
. 2014 Oct 21;12:291. doi: 10.1186/s12967-014-0291-1

Figure 1.

Figure 1

Ipilimumab clinical activity (OS) irrespective of BRAF mutational status: the Italian EAP in melanoma by Ascierto et al. J Trans Med 2014; 12: 116–122 [ 26 ].